1. Home
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
Asparaginase Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type, Application, End-Use Industry, and Geography

Asparaginase Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type, Application, End-Use Industry, and Geography

  • August 2022
  • 176 pages
  • ID: 6321015
  • Format: PDF
  • The Insight Partners

Summary

Table of Contents

Search Inside

The global asparaginase market is expected to grow from US$ 564.01 million in 2021 to US$ 1,575.62 million by 2028. It is expected to grow with a CAGR of 16.1% from 2022 to 2028.

The rising incidence of leukemia and the significant growth in the pharmaceutical and food industry are the major factors boosting the market.
Asparaginase is a naturally occurring substance that is present in mammals, birds, yeast, plants, and different types of bacteria but Enterobacteriaceae family microorganisms are one of the primary sources of L-asparaginase production.Additionally, there is various research going on for the expansion of its application area in different industries, such as nanomedicine, biomedical engineering, and many more, which is contributing to the market growth.

Furthermore, increasing allergic reactions from E. coli, derived L-asparaginase has increased the use of E. chrysanthemi derived L-Asparaginase. Furthermore, the rising demand for better stability in the pharmaceutical industry to ensure efficient storage and transportation of drugs has further increased the R&D activities in the industry. There has been a rising inclination toward lyophilized drugs due to various advantages associated with lyophilized drugs. Thus, all the factors mentioned above are expected to drive the asparaginase market growth in the near future.
Moreover, the increase in population worldwide has further contributed to the growth of the pharmaceutical and food industries.The rising population is fueling the demand for food products and pharmaceuticals.

As per the world bank data, the total population was estimated to be 7.84 billion globally in 2021, growing at the rate of 1.05% per year. Thus, an increasing population is contributing to the expansion in the food and pharmaceutical industries, driving the global asparaginase market.
Global Asparaginase Market: Key Insights – Impact of COVID-19 Pandemic
The COVID-19 pandemic offered lucrative opportunities to players operating in the global asparaginase market.The US emerged as one of the most affected countries in North America due to the COVID-19 pandemic.

The infection severely affected the country’s geriatric population, leading to various health complications among them, followed by the death of a large population.
During COVID-19 has Spain, Italy, UK, France, and Germany were the worst affected European countries.According to Spanish Ministry of Health’s report, 2020, about 1,773,000 cases and 48,000 deaths of COVID-19 were reported in Spain.

About 20% of cases were registered in the Community of Madrid, accounting for 11,000 deaths and makes it severely affected areas in Europe.Cancer patients are at high risk of contracting COVID-19 and severe complications.

Due to sudden lockdown and movement restriction, only emergency procedures were allowed.Asia Pacific was the first region to face an outbreak, the region has quickly changed how they manage trials, and most are able to deliver the clinical trial services their clients need.

Biotech companies are currently initiating more clinical trials in the region. For Instance: since the initial outbreak, the situation in Asia Pacific has improved. As of May 2020, 97% of the sites re-opened for patient visits and 83% of the sites are open for on-site CRA visits. While in MEA and SCAM region COVID-19 pandemic had slight negative impact on the asparaginase market growth.
Type Insights
Based on the type, the global asparaginase market is segmented into Escherichia coli (E. coli), Erwina Chrysanthemi, Pegylated, and others. The E. coli segment held the largest market share in 2021. It is anticipated to register the highest CAGR during the forecast period. The increasing demand for E. coli asparaginase in the cancer treatment and food processing industry promotes the growth of the global asparaginase market. Asparaginase-derived E. coli is used for the treatment of acute lymphoblastic leukemias. Asparaginase E. coli is an enzyme that catalyzes L-asparagine into L-aspartic acid and ammonia. It helps in the production of oxaloacetate needed for cellular metabolism. Asparaginase from E. coli has an antitumor property that is used for the treatment of leukemias.
Application Insights
Based on application, the global asparaginase market is bifurcated into therapeutic, food processing, and others.The therapeutic segment held a larger market share in 2021.

Furthermore, the same segment is expected to record a faster CAGR from 2022 to 2028.The increasing use of asparaginase enzyme in treating lymphoproliferative disorders and lymphomas is expected to drive the growth of this segment during the forecasted period.

The asparaginase enzyme is also used as an antimicrobial agent to treat infectious and autoimmune diseases, among others. It is administrated by injection into a vein, muscle, or under the skin.
The demand for asparaginase enzyme is growing in the food processing industry as it reduces the acrylamide formation in the food under specific cooking conditions.Continuous innovations and increased demand for processed food are driving the growth of the global asparaginase market.

According to the European Food Safety Authority (EFSA 2015), use of L-asparaginase presents a high potential to reduce the acrylamide content in thermally treated food without compromising their sensorial or nutritional aspects.

End-use Industry Insights
Based on end-use industry, the global asparaginase market is segmented into healthcare and food manufacturing.In 2021, the healthcare segment held the largest share in the market.

Furthermore, the same segment is expected to register the highest CAGR from 2022 to 2028. The growth of the healthcare segment is attributed to factors such as growing acute lymphocytic leukemia, lymphoblastic lymphoma, and growing research activities.
The rapidly growing healthcare industry is expected to increase the demand for asparaginase during the forecast period.Due to the increasing demand for asparaginase, there is a rising investment by the market players in R&D and the production of asparaginase.

For instance, In 2019, researchers at the University of Illinois, Chicago, secured about US$ 1 million in funding for developing a less toxic version of chemotherapy using asparaginase to treat acute lymphoblastic leukemia. Thus, the rise in research activities is anticipated to boost the growth of the global asparaginase market during the forecast period.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Grace helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Embolotherapy Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product, Disease Indication, Procedure, and End User

  • $ 4550
  • August 2022
  • 255 pages

The embolotherapy market is expected to grow from US$ 3,341.49 million in 2021 to US$ 5,758.28 million by 2028; it is estimated to grow at a CAGR of 8.1% from 2022 to 2028. The report highlights trends ...

  • World
  • APAC
  • Pathology
  • Cancer
  • Industry analysis
  • Cancer Incidence
  • Mortality Rate

Anti-Tumor Drugs Markets in China $ 4000 October 2022


ref:plp2022

Reportlinker.com © Copyright 2022. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on